We are live on ! Find out more
PCM

Piermont Capital Management Portfolio holdings

AUM $211M
1-Year Est. Return 8.09%
This Fund
S&P 500
This Quarter Est. Return
+0.96%
1 Year Est. Return
-8.09%
3 Year Est. Return
+33.18%
5 Year Est. Return
+53.13%
10 Year Est. Return
AUM
$350M
AUM Growth
-$69.9M
Cap. Flow
-$68.2M
Cap. Flow %
-19.5%
Top 10 Hldgs %
10.28%
Holding
280
New
38
Increased
14
Reduced
162
Closed
35

Sector Composition

Rank Sector Weight
1 Financials 21.43%
2 Industrials 14.97%
3 Technology 13.73%
4 Consumer Discretionary 12.59%
5 Healthcare 11.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FOSL icon
226
Fossil Group
FOSL
$316M
$517K 0.15%
49,930
-13,060
-21% -$177K
THFF icon
227
First Financial Corp
THFF
$942M
$503K 0.14%
10,630
-2,681
-20% -$127K
AMPH icon
228
Amphastar Pharmaceuticals
AMPH
$936M
$492K 0.14%
27,523
-5,160
-16% -$81.8K
CYTK icon
229
Cytokinetics
CYTK
$10B
$489K 0.14%
40,418
-7,200
-15% -$100K
LXRX icon
230
Lexicon Pharmaceuticals
LXRX
$1.02B
$489K 0.14%
29,710
-5,160
-15% -$79.9K
ARRY
231
DELISTED
Array Biopharma Inc
ARRY
$446K 0.13%
53,300
-9,600
-15% -$78.5K
XNCR icon
232
Xencor
XNCR
$1.94B
$443K 0.13%
20,963
-3,660
-15% -$82K
PBPB
233
DELISTED
Potbelly
PBPB
$441K 0.13%
38,368
-6,840
-15% -$83.5K
URBN icon
234
Urban Outfitters
URBN
$6.95B
$439K 0.13%
23,680
ANDV
235
DELISTED
Andeavor
ANDV
$433K 0.12%
4,630
CSOD
236
DELISTED
Cornerstone OnDemand, Inc.
CSOD
$413K 0.12%
11,540
-2,070
-15% -$77.5K
UTHR icon
237
United Therapeutics
UTHR
$22.1B
$401K 0.11%
+3,090
New +$385K
AEE icon
238
Ameren
AEE
$29.4B
$396K 0.11%
7,250
NTUS
239
DELISTED
Natus Medical Inc
NTUS
$390K 0.11%
10,460
-1,860
-15% -$67.2K
CIVI
240
DELISTED
Civitas Solutions, Inc.
CIVI
$388K 0.11%
22,196
-4,140
-16% -$71.7K
FLR icon
241
Fluor
FLR
$7.12B
$384K 0.11%
8,380
ASRT
242
DELISTED
Assertio
ASRT
$365K 0.1%
566
-101
-15% -$67.3K
KDNY
243
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$351K 0.1%
6,160
-1,020
-14% -$51.2K
IPGP icon
244
IPG Photonics
IPGP
$3.26B
$268K 0.08%
+1,850
New +$248K
AMAG
245
DELISTED
AMAG Pharmaceuticals
AMAG
$233K 0.07%
12,670
-2,280
-15% -$45.2K
ARAY icon
246
Accuray
ARAY
$32.7M
-195,272
Closed -$928K
EFOR
247
Everforth Inc
EFOR
$1.31B
-31,060
Closed -$1.51M
BJRI icon
248
BJ's Restaurants
BJRI
$1.39B
-23,574
Closed -$952K
CASY icon
249
Casey's General Stores
CASY
$28B
-5,190
Closed -$583K
CENT icon
250
Central Garden & Pet Co
CENT
$2.74B
-76,098
Closed -$2.26M

Similar funds

Piermont Capital Management's Q2 2017 Portfolio in Review

As of Q2 2017, Piermont Capital Management held 280 positions worth $350M, down 17% from $420M the previous quarter. Its ten largest holdings account for 10% of the portfolio.

Piermont Capital Management withdrew a net $68.2M in Q2 2017, closing 35 positions and reducing 162 holdings. Its most notable exit was Timken Company, an estimated $3.6M position sold in full.

By sector, the portfolio is most concentrated in Financials at 21% of assets, down from 22% a quarter earlier, followed by Industrials and Technology.

Against the trend, Piermont Capital Management opened a new position in Franklin Street Properties worth $2.36M.

  • Piermont Capital Management's largest Q2 2017 buy was Franklin Street Properties: 213,150 shares worth $2.36M.
  • Piermont Capital Management added most to Cooper-Standard Automotive in Q2 2017, an estimated $2.14M increase.
  • Piermont Capital Management's biggest Q2 2017 reduction was Rambus, cutting an estimated $3.1M.
  • Piermont Capital Management fully exited Timken Company in Q2 2017, selling an estimated $3.6M.
  • Piermont Capital Management's ten largest holdings make up 10% of its $350M portfolio in Q2 2017.
  • Piermont Capital Management opened 38 new positions and closed 35 in Q2 2017.
  • Piermont Capital Management's portfolio value fell 17% quarter-over-quarter to $350M.

Based on Piermont Capital Management's 13F filing for Q2 2017, filed 11 Aug 2017.